Lupus Research Alliance Issues Statement June 4, 2020
June 4, 2020
Racism, bigotry, intolerance and violence are hateful and have no place in American society.
The Lupus Research Alliance...
News
Positive Data from Trial of Investigational Treatment KZR-616 for Lupus and Lupus Nephritis
June 3, 2020
Kezar Life Sciences, Inc. today announced updated results from the Phase 1b (Ph1b) portion of MISSION, a...
LRA Congratulates AstraZeneca on Positive Data on Anifrolumab Presented at Major Medical Meeting
June 3, 2020
The Lupus Research Alliance (LRA) is encouraged by positive data from two studies presented at the European...
Aurinia Completes NDA and Requests Priority Review of Voclosoporin by FDA for Lupus Nephritis
May 28, 2020
The Lupus Research Alliance is pleased to share that Aurinia Pharmaceuticals Inc submitted a New Drug Application...
COVID-19 Caused Hydroxychloroquine Issues for Third of Lupus Patients, New LRA Survey Finds
NEW YORK, NY, May 28, 2020. More than one third of people with lupus experienced significant issues filling their...
Lupus and COVID-19: What You Need to Know – LIVE WEBCAST May 21 at 6 PM ET
Since the arrival of the novel coronavirus, lupus and the most prescribed drug used to treat it – hydroxychloroquine...
Remembering Betty Wold Johnson, A Major LRA Friend and Benefactor
May 2020
The entire Board of Trustees and staff of the Lupus Research Alliance (LRA) and Lupus Therapeutics (LT) mourn...
Lupus Research Alliance Thanks FDA for Responsiveness Re Letter Citing Plaquenil Shortages
May 7, 2020
The Lupus Research Alliance held an informative call with the Food and Drug Administration (FDA) in response...
Lupus Research Alliance Launches Learn From Lupus Campaign for Lupus Awareness Month
May 1, 2020
In the context of the COVID-19 crisis, one disease has taken center stage as the world found...
Lupus Research Alliance Encouraged by Lilly Looking at Potential Lupus Drug for COVID-19
April 23, 2020
The Lupus Research Alliance is pleased to share that Eli Lilly and Company entered into an agreement...
New LRA-Supported Study Discovers STAT1, a Highly Specific Target for Potential New Therapy
April 23, 2020
A new study supported by the Lupus Research Alliance discovered a way that harmful immune responses in...
New Data Points Away from Hydroxychloroquine as COVID-19 Treatment
Updated April 23, 2020
The most commonly prescribed treatment for lupus, hydroxychloroquine (best known as Plaquenil) is not effective for...